Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study

Yu K.-H.Lai J.-H.PING-NING HSUChen D.-Y.Chen C.-J.Lin H.-Y.2021-02-022021-02-0220160300-9742https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954466420&doi=10.3109%2f03009742.2015.1099729&partnerID=40&md5=b8adf65adeaff1983a54b75ee1e38094https://scholars.lib.ntu.edu.tw/handle/123456789/545294Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled studyjournal article10.3109/03009742.2015.1099729267714452-s2.0-84954466420